Boxer Capital’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-500,000
| Closed | -$535K | – | 74 |
|
|
2023
Q3 | $535K | Hold |
500,000
| – | – | 0.03% | 68 |
|
|
2023
Q2 | $1.3M | Hold |
500,000
| – | – | 0.06% | 72 |
|
|
2023
Q1 | $2.04M | Hold |
500,000
| – | – | 0.1% | 66 |
|
|
2022
Q4 | $2.51M | Hold |
500,000
| – | – | 0.13% | 56 |
|
|
2022
Q3 | $6.54M | Hold |
500,000
| – | – | 0.37% | 46 |
|
|
2022
Q2 | $6.41M | Hold |
500,000
| – | – | 0.41% | 47 |
|
|
2022
Q1 | $7.63M | Hold |
500,000
| – | – | 0.39% | 47 |
|
|
2021
Q4 | $8.86M | Hold |
500,000
| – | – | 0.34% | 47 |
|
|
2021
Q3 | $10.5M | Hold |
500,000
| – | – | 0.37% | 59 |
|
|
2021
Q2 | $9.86M | Buy |
+500,000
| New | +$9.86M | 0.35% | 65 |
|